BIVIGAM (Biotest Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the BIVIGAM drug offered from Biotest Pharmaceuticals Corporation. This Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Biotest Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | HUMAN IMMUNOGLOBULIN G |
| SUBSTANCE NAME: | HUMAN IMMUNOGLOBULIN G |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2013-02-04 |
| END MARKETING DATE: | 0000-00-00 |
BIVIGAM PLASMA DERIVATIVE Details:
| Item Description | BIVIGAM from Biotest Pharmaceuticals Corporation |
| LABELER NAME: | Biotest Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(g/50mL) |
| START MARKETING DATE: | 2013-02-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59730-6502_8a435c1e-ca3a-40aa-b0b2-46cf6fdd1d02 |
| PRODUCT NDC: | 59730-6502 |
| APPLICATION NUMBER: | BLA125389 |
Other HUMAN IMMUNOGLOBULIN G Pharmaceutical Manufacturers / Labelers:
